Search Results 241-250 of 18134 for monoclonal antibody

  1. A Study Comparing Anitocabtagene Autoleucel To Standard Of Care Therapy In Participants With Relapsed/ Refractory Multiple Myeloma (IMMagine-3) - Mayo Clinic

    ... monoclonal antibody and an immunomodulatory drug. The primary objective of this study is to compare the efficacy of anitocabtagene autoleucel versus SOCT in ...

  2. Clinical trials - Oncology (Medical)

    Rituximab is a monoclonal antibody. It binds to a protein called CD20, which is found on B cells (a type of white blood cell) and some types of cancer cells ...

  3. Medical Research & Education - Mayo Clinic News Network

    Monoclonal antibody treatment combo reduces hospitalization among high-risk patients with COVID-19 featured. Featured News. Monoclonal antibody treatment ...

  4. Balancing the risks of antiamyloid therapies - Mayo Clinic

    Monoclonal antibody medication can slow the progression of early Alzheimer's disease. But some patients on those therapies can experience edema or ...

  5. A Study Of Copanlisib And Nivolumab In Treating Participants With Recurrent Or Refractory Diffuse Large B-cell Lymphoma Or Primary Mediastinal Large B-cell Lymphoma - Mayo Clinic

    Copanlisib may stop the growth of tumor cells by blocking some of the enzymes needed for cell growth. Monoclonal antibodies, such as nivolumab, may interfere ...

  6. Clinical trials - Oncology (Medical)

    Inotuzumab ozogamicin is a monoclonal antibody, called inotuzumab, linked to a type of chemotherapy called calicheamicin. Inotuzumab attaches to cancer ...

  7. A Study Of Nivolumab And Multi-fraction Stereotactic Radiosurgery With Or Without Ipilimumab In Treating Participants With Recurrent Grade II-III Meningioma - Mayo Clinic

    Monoclonal antibodies, such as nivolumab and ipilimumab, may interfere with the ... History of severe hypersensitivity reaction to any monoclonal antibody.

  8. Neuromyelitis optica: New therapies offer hope - Mayo Clinic

    The newly approved treatments are three monoclonal antibodies: ... Rituximab, a monoclonal antibody often used to treat NMOSD , costs about $18,000 a year.

  9. Clinical trials - Oncology (Medical)

    Rituximab is a monoclonal antibody that may interfere with the ability of cancer cells to grow and spread. ... Monoclonal antibodies, such as obinutuzumab, may ...

  10. Oncology (Medical) - Clinical trials

    Rituximab is a monoclonal antibody that may interfere with the ability of cancer cells to grow and spread. ... Monoclonal antibodies, such as obinutuzumab, may ...